IL6 and chronic obstructive pulmonary disease: This study, combined with the above reports, all suggest that the mechanism of action of BIPAP on the improvement of COPD symptoms and anxiety and depression mood may have a close bearing on the reduction of 5-HT, NKA and IL-6 levels.